Brand name GLP-1s like Ozempic, Trulicity, and Victoza (among others) have long been used in the treatment of type 2 diabetes specifically
One particular concern is the risk of cancer
Nowadays, LY3502790 and PF-06882961 (231233), a class of oral non-peptide small molecule GLP-1RAs with preferable efficacy and anti-diabetes potential, are at the stage of pre-clinical research
Some people stop GLP-1 medications suddenly, while others gradually reduce their dose over time
The more slowly food moves through your digestive tract, the smaller your appetite
Most physician-supervised protocols use cycles rather than continuous use: 4 weeks for mild issues, 6 to 8 weeks for moderate injuries or gut healing, and 8 to 12 weeks for severe cases